Guided Therapeutics Inc (GTHP) stock
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.16−0.03 (-15.79%)
Close on Oct 19, 2026Market cap $15.45MP/E –Yield –
Guided Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Guided Therapeutics's ebitda for the twelve months ending Dec 31, 2020 was -$1.05M. For fiscal 2020 it was -$1.05M. The highest annual figure on record is -$916.00K in fiscal 2019.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -$1.05M | – |
| FY2019 | Dec 31, 2019 | -$916.00K | – |
| FY2018 | Dec 31, 2018 | -$1.52M | – |
| FY2017 | Dec 31, 2017 | -$2.91M | – |
| FY2016 | Dec 31, 2016 | -$2.60M | – |
| FY2015 | Dec 31, 2015 | -$5.17M | – |
| FY2014 | Dec 31, 2014 | -$7.43M | – |
| FY2013 | Dec 31, 2013 | -$6.15M | – |
| FY2012 | Dec 31, 2012 | -$3.92M | – |
| FY2011 | Dec 31, 2011 | -$6.72M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | -$288.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$153.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$369.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$242.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$165.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$188.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$311.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$252.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$444.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$229.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$480.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$370.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$595.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.32M | – |
| Q2 FY2017 | Jun 30, 2017 | -$510.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$477.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$39.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$633.00K | – |
See a number that looks wrong?